Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 240 articles:
HTML format
Text format



Single Articles


    December 2018
  1. EILERTSON B
    CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City-author response.
    J Antimicrob Chemother. 2018 Dec 5. pii: 5231911. doi: 10.1093.
    PubMed     Text format    


  2. BRENCIANI A, Fioriti S, Morroni G, Cucco L, et al
    Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230877. doi: 10.1093.
    PubMed     Text format    


    November 2018
  3. WYRES KL, Lam MMC, Holt KE
    Comment on: CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.
    J Antimicrob Chemother. 2018 Nov 30. pii: 5224781. doi: 10.1093.
    PubMed     Text format    


  4. PULCINI C, Clerc-Urmes I, Attinsounon CA, Fougnot S, et al
    Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study.
    J Antimicrob Chemother. 2018 Nov 30. pii: 5224777. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. DENISUIK AJ, Garbutt LA, Golden AR, Adam HJ, et al
    Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
    J Antimicrob Chemother. 2018 Nov 29. pii: 5219007. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. RAM M R, Teh X, Rajakumar T, Goh KL, et al
    Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.
    J Antimicrob Chemother. 2018 Nov 6. pii: 5162962. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. SHERRARD LJ, Schaible B, Graham KA, McGrath SJ, et al
    Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.
    J Antimicrob Chemother. 2018;73:3218.
    PubMed     Text format    


    October 2018
  8. COPPRY M, Jeanne-Leroyer C, Noize P, Dumartin C, et al
    Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146515. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. HSUEH SC, Lee YJ, Huang YT, Liao CH, et al
    In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstr
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144002. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. BROSH-NISSIMOV T, Navon-Venezia S, Keller N, Amit S, et al
    Risk analysis of antimicrobial resistance in outpatient urinary tract infections of young healthy adults.
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144000. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. RECACHA E, Machuca J, Diaz-Diaz S, Garcia-Duque A, et al
    Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.
    J Antimicrob Chemother. 2018 Oct 16. pii: 5133291. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. TSANG RSW, Ahmad T, Jamieson FB, Tyrrell GJ, et al
    WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 beta-lactamase gene.
    J Antimicrob Chemother. 2018 Oct 8. pii: 5123547. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. KIM D, Park BY, Choi MH, Yoon EJ, et al
    Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116214. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. EILERTSON B, Chen L, Li A, Chavda KD, et al
    CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5113246. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  15. ZHOU X, Chlebowicz MA, Bathoorn E, Rosema S, et al
    Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.
    J Antimicrob Chemother. 2018 Sep 14. pii: 5096847. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. SCHMIDT VM, Pinchbeck G, McIntyre KM, Nuttall T, et al
    Routine antibiotic therapy in dogs increases the detection of antimicrobial-resistant faecal Escherichia coli.
    J Antimicrob Chemother. 2018 Sep 11. pii: 5095201. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. TAGG KA, Francois Watkins L, Moore MD, Bennett C, et al
    Novel trimethoprim resistance gene dfrA34 identified in Salmonella Heidelberg in the USA.
    J Antimicrob Chemother. 2018 Sep 10. pii: 5094565. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. CABOT G, Florit-Mendoza L, Sanchez-Diener I, Zamorano L, et al
    Deciphering beta-lactamase-independent beta-lactam resistance evolution trajectories in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2018 Sep 5. pii: 5091007. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. LEE RS, Goncalves da Silva A, Baines SL, Strachan J, et al
    The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090546. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. JORGENSEN SCJ, McDonald P, Mynatt RP, Pogue JM, et al
    Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090540. doi: 10.1093.
    PubMed     Text format    


    August 2018
  21. CASELLA T, Haenni M, Madela NK, Andrade LK, et al
    Extended-spectrum cephalosporin-resistant Escherichia coli isolated from chickens and chicken meat in Brazil is associated with rare and complex resistance plasmids and pandemic ST lineages.
    J Antimicrob Chemother. 2018 Aug 31. pii: 5088381. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed     Text format    


  23. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. DEWAN KK, Skarlupka AL, Rivera I, Cuff LE, et al
    Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence.
    J Antimicrob Chemother. 2018 Aug 10. pii: 5069478. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  25. WILSON RE, Hill RLR, Chalker VJ, Mentasti M, et al
    Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
    J Antimicrob Chemother. 2018 Jul 24. pii: 5057980. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. MEYGRET A, Le Roy C, Renaudin H, Bebear C, et al
    Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015.
    J Antimicrob Chemother. 2018 Jul 6. pii: 5050099. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. VELOO ACM, Chlebowicz M, Winter HLJ, Bathoorn D, et al
    Three metronidazole-resistant Prevotella bivia strains harbour a mobile element, encoding a novel nim gene, nimK, and an efflux small MDR transporter.
    J Antimicrob Chemother. 2018 Jul 2. pii: 5047838. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  28. BARBER KE, Pogue JM, Warnock HD, Bonomo RA, et al
    Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2018 Jun 22. pii: 5043126. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036449. doi: 10.1093.
    PubMed     Text format    


  30. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036451. doi: 10.1093.
    PubMed     Text format    


  31. ZONG Z, Fenn S, Connor C, Feng Y, et al
    Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035906. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. FARKAS A, Sassine J, Mathew JP, Stavropoulos C, et al
    Outcomes associated with the use of a revised risk assessment strategy to predict antibiotic resistance in community-onset pneumonia: a stewardship perspective.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035907. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  33. LIN JN, Lai CH, Yang CH, Huang YH, et al
    Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2018 May 28. pii: 5017392. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. BACHIR M, Allem R, Benejat L, Tifrit A, et al
    Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
    J Antimicrob Chemother. 2018 May 11. pii: 4995220. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. NYGAARD JENSEN J, Melander E, Hedin K, Bjerrum L, et al
    Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions.
    J Antimicrob Chemother. 2018 May 10. pii: 4995081. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  36. GUPTA P, Mankere B, Chekkoora Keloth S, Tuteja U, et al
    Increased antibiotic resistance exhibited by the biofilm of Vibrio cholerae O139.
    J Antimicrob Chemother. 2018 Apr 24. pii: 4984488. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. SIMNER PJ, Antar AAR, Hao S, Gurtowski J, et al
    Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2018 Apr 10. pii: 4966148. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study-authors' response.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960907. doi: 10.1093.
    PubMed     Text format    


  39. ANTONELLI A, D'Andrea MM, Brenciani A, Galeotti CL, et al
    Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960904. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  41. TORUMKUNEY D, Papaparaskevas J, Morrissey I
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  42. TORUMKUNEY D, Zemlickova H, Maruscak M, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  43. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  44. TORUMKUNEY D, Mayanskiy N, Edelstein M, Sidorenko S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


    March 2018
  45. SCHNEIDER S, Salm F, Vincze S, Moeser A, et al
    Perceptions and attitudes regarding antibiotic resistance in Germany: a cross-sectoral survey amongst physicians, veterinarians, farmers and the general public.
    J Antimicrob Chemother. 2018 Mar 26. pii: 4953726. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. WAREHAM DW, Phee LM, Abdul Momin MHF
    Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951547. doi: 10.1093.
    PubMed     Text format    


  47. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. PRICE L, Gozdzielewska L, Young M, Smith F, et al
    Effectiveness of interventions to improve the public's antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937884. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. ASHLEY EA, Recht J, Chua A, Dance D, et al
    An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
    J Antimicrob Chemother. 2018 Mar 5. pii: 4921008. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  50. ROHDE AM, Wiese-Posselt M, Zweigner J, Schwab F, et al
    High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
    J Antimicrob Chemother. 2018 Feb 27. pii: 4911557. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. HEMARAJATA P, Amick T, Yang S, Gregson A, et al
    Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    J Antimicrob Chemother. 2018 Feb 19. pii: 4877955. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. DAMIAO GOUVEIA AC, Unemo M, Jensen JS
    In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains.
    J Antimicrob Chemother. 2018 Feb 12. pii: 4850948. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  54. POUWELS KB, Freeman R, Muller-Pebody B, Rooney G, et al
    Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4832009. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. BRYCE A, Costelloe C, Wootton M, Butler CC, et al
    Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study.
    J Antimicrob Chemother. 2018 Jan 29. pii: 4828185. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. PARTRIDGE SR, Tsafnat G
    Automated annotation of mobile antibiotic resistance in Gram-negative bacteria: the Multiple Antibiotic Resistance Annotator (MARA) and database.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823430. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. XIE M, Li R, Liu Z, Chan EWC, et al
    Recombination of plasmids in a carbapenem-resistant NDM-5-producing clinical Escherichia coli isolate.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823432. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. ROZWANDOWICZ M, Brouwer MSM, Fischer J, Wagenaar JA, et al
    Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4822282. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. TEBANO G, la Martire G, Sarmento N, Francis JR, et al
    Antibiotic resistance in Timor-Leste: a systematic review of evidence.
    J Antimicrob Chemother. 2018 Jan 22. pii: 4819241. doi: 10.1093.
    PubMed     Text format    


  60. BASUINO L, Jousselin A, Alexander JAN, Strynadka NCJ, et al
    PBP4 activity and its overexpression are necessary for PBP4-mediated high-level beta-lactam resistance.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817624. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. HAENSSGEN MJ, Charoenboon N, Khine Zaw Y
    It is time to give social research a voice to tackle antimicrobial resistance?
    J Antimicrob Chemother. 2018 Jan 18. pii: 4817296. doi: 10.1093.
    PubMed     Text format    


  62. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. CESARO S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, et al
    ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.
    J Antimicrob Chemother. 2018;73:12-21.
    PubMed     Text format     Abstract available


  65. ZHOU K, Yu W, Cao X, Shen P, et al
    Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China.
    J Antimicrob Chemother. 2018;73:66-76.
    PubMed     Text format     Abstract available


  66. CASTAGNA A, Ferrara M, Galli L, Comi L, et al
    Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.
    J Antimicrob Chemother. 2018;73:177-182.
    PubMed     Text format     Abstract available


  67. PERRIER M, Visseaux B, Landman R, Joly V, et al
    No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
    J Antimicrob Chemother. 2018;73:173-176.
    PubMed     Text format     Abstract available


  68. KENGKLA K, Kongpakwattana K, Saokaew S, Apisarnthanarak A, et al
    Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
    J Antimicrob Chemother. 2018;73:22-32.
    PubMed     Text format     Abstract available


  69. HEIDARY M, Khosravi AD, Khoshnood S, Nasiri MJ, et al
    Daptomycin.
    J Antimicrob Chemother. 2018;73:1-11.
    PubMed     Text format     Abstract available


  70. LIVERMORE DM, Mushtaq S, Warner M, Turner SJ, et al
    Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens.
    J Antimicrob Chemother. 2018;73:126-133.
    PubMed     Text format     Abstract available


  71. MALCOLM W, Fletcher E, Kavanagh K, Deshpande A, et al
    Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform.
    J Antimicrob Chemother. 2018;73:223-230.
    PubMed     Text format     Abstract available


  72. JIN L, Wang R, Wang X, Wang Q, et al
    Emergence of mcr-1 and carbapenemase genes in hospital sewage water in Beijing, China.
    J Antimicrob Chemother. 2018;73:84-87.
    PubMed     Text format     Abstract available


  73. THAKUR SD, Levett PN, Horsman GB, Dillon JR, et al
    High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
    J Antimicrob Chemother. 2018;73:118-125.
    PubMed     Text format     Abstract available


  74. LI Y, Li Y, Fernandez Crespo R, Leanse LG, et al
    Characterization of the Actinobacillus pleuropneumoniae SXT-related integrative and conjugative element ICEApl2 and analysis of the encoded FloR protein: hydrophobic residues in transmembrane domains contribute dynamically to florfenicol and chloramph
    J Antimicrob Chemother. 2018;73:57-65.
    PubMed     Text format     Abstract available


  75. LAI MT, Tawa P, Auger A, Wang D, et al
    Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors.
    J Antimicrob Chemother. 2018;73:109-117.
    PubMed     Text format     Abstract available


  76. BOTELHO J, Grosso F, Peixe L
    Unravelling the genome of a Pseudomonas aeruginosa isolate belonging to the high-risk clone ST235 reveals an integrative conjugative element housing a blaGES-6 carbapenemase.
    J Antimicrob Chemother. 2018;73:77-83.
    PubMed     Text format     Abstract available


    December 2017
  77. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. DECROO T, Van Deun A, Lynen L
    Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774628. doi: 10.1093.
    PubMed     Text format    


  79. KLOTZ P, Jacobmeyer L, Stamm I, Leidner U, et al
    Carbapenem-resistant Acinetobacter baumannii ST294 harbouring the OXA-72 carbapenemase from a captive grey parrot.
    J Antimicrob Chemother. 2017 Dec 21. pii: 4772354. doi: 10.1093.
    PubMed     Text format    


  80. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748887. doi: 10.1093.
    PubMed     Text format    


  81. WOODFORD N, Xu-McCrae L, Mushtaq S, Wu HHT, et al
    Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748884. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. CASPAR Y, Hennebique A, Maurin M
    Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745834. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. HARRIS PNA, Ben Zakour NL, Roberts LW, Wailan AM, et al
    Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745835. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. DAY MR, Doumith M, Do Nascimento V, Nair S, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693726. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  85. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. FJALSTAD JW, Esaiassen E, Juvet LK, van den Anker JN, et al
    Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4652876. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. LEE RS, Seemann T, Heffernan H, Kwong JC, et al
    Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4647718. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. CAI Y, Yang D, Wang J, Wang R, et al
    Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. MARQUES C, Belas A, Franco A, Aboim C, et al
    Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. KOSHKOLDA T, Luck C
    Antibiotic susceptibility of clinical Legionella pneumophila serogroup 1 strains isolated in Germany.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format    


    October 2017
  91. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format    


  95. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  96. JIMENEZ-CASTELLANOS JC, Wan Nur Ismah WAK, Takebayashi Y, Findlay J, et al
    Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired beta-lactam resistance.
    J Antimicrob Chemother. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries-authors' response.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    


  98. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Text format     Abstract available


  100. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Text format     Abstract available


  101. ZANKARI E, Allesoe R, Joensen KG, Cavaco LM, et al
    PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens.
    J Antimicrob Chemother. 2017;72:2764-2768.
    PubMed     Text format     Abstract available


  102. OVIANO M, Gomara M, Barba MJ, Sparbier K, et al
    Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2952-2954.
    PubMed     Text format    


  103. LEE MC, Sun PL, Wu TL, Wang LH, et al
    Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    J Antimicrob Chemother. 2017;72:2782-2786.
    PubMed     Text format     Abstract available


  104. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Text format     Abstract available


  105. WEBBER MA, Buckner MMC, Redgrave LS, Ifill G, et al
    Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan.
    J Antimicrob Chemother. 2017;72:2755-2763.
    PubMed     Text format     Abstract available


  106. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Text format     Abstract available


    September 2017
  107. ARANA DM, Ortega A, Gonzalez-Barbera E, Lara N, et al
    Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. ZHANG Q, Hua X, Ruan Z, Yu Y, et al
    Revisiting the contribution of gene duplication of blaOXA-23 in carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format    


  109. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  110. PULCINI C
    Comment on: National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Sep 18. doi: 10.1093.
    PubMed     Text format    


  111. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  112. DO NASCIMENTO V, Day MR, Doumith M, Hopkins KL, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015-16.
    J Antimicrob Chemother. 2017 Sep 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  115. LEE GC, Dallas SD, Wang Y, Olsen RJ, et al
    Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization.
    J Antimicrob Chemother. 2017;72:2461-2468.
    PubMed     Text format     Abstract available


    August 2017
  116. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  117. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  118. ATKINSON CT, Kunde DA, Tristram SG
    Expression of acquired macrolide resistance genes in Haemophilus influenzae.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. PRASKI ALZRIGAT L, Huseby DL, Brandis G, Hughes D, et al
    Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. NIGRO SJ, Hall RM
    A large plasmid, pD46-4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format    


  121. HOMBACH M, Jetter M, Keller PM, Blochliger N, et al
    Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  122. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. ZELLWEGER RM, Carrique-Mas J, Limmathurotsakul D, Day NPJ, et al
    A current perspective on antimicrobial resistance in Southeast Asia.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Text format     Abstract available


  126. ROMINSKI A, Selchow P, Becker K, Brulle JK, et al
    Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes.
    J Antimicrob Chemother. 2017;72:2191-2200.
    PubMed     Text format     Abstract available


  127. BRENNER BG, Ibanescu RI, Oliveira M, Roger M, et al
    HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.
    J Antimicrob Chemother. 2017;72:2171-2183.
    PubMed     Text format     Abstract available


  128. SOULIE C, Grude M, Descamps D, Amiel C, et al
    Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    J Antimicrob Chemother. 2017;72:2351-2354.
    PubMed     Text format     Abstract available


  129. OVIANO M, Gomara M, Barba MJ, Revillo MJ, et al
    Towards the early detection of beta-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.
    J Antimicrob Chemother. 2017;72:2259-2262.
    PubMed     Text format     Abstract available


    July 2017
  130. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. KWON HI, Kim S, Oh MH, Na SH, et al
    Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain.
    J Antimicrob Chemother. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  133. HAMIDIAN M, Hall RM
    Origin of the AbGRI1 antibiotic resistance island found in the comM gene of Acinetobacter baumannii GC2 isolates.
    J Antimicrob Chemother. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format    


  134. DI SANTE L, Morroni G, Brenciani A, Vignaroli C, et al
    pHTbeta-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis.
    J Antimicrob Chemother. 2017 Jun 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. VOURLI S, Dafopoulou K, Vrioni G, Tsakris A, et al
    Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. TOMASO H, Hotzel H, Otto P, Myrtennas K, et al
    Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. BUIL JB, Rijs AJMM, Meis JF, Birch M, et al
    In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    J Antimicrob Chemother. 2017 Jun 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. POWELL N, Davidson I, Yelling P, Collinson A, et al
    Developing a local antimicrobial resistance action plan: the Cornwall One Health Antimicrobial Resistance Group.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. SADOUKI Z, Day MR, Doumith M, Chattaway MA, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales, 2015.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. STANCZAK-MROZEK KI, Laing KG, Lindsay JA
    Resistance gene transfer: induction of transducing phage by sub-inhibitory concentrations of antimicrobials is not correlated to induction of lytic phage.
    J Antimicrob Chemother. 2017;72:1624-1631.
    PubMed     Text format     Abstract available


  141. MUSICHA P, Feasey NA, Cain AK, Kallonen T, et al
    Genomic landscape of extended-spectrum beta-lactamase resistance in Escherichia coli from an urban African setting.
    J Antimicrob Chemother. 2017;72:1602-1609.
    PubMed     Text format     Abstract available


  142. MUSHTAQ S, Vickers A, Woodford N, Livermore DM, et al
    WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D beta-lactamases.
    J Antimicrob Chemother. 2017;72:1688-1695.
    PubMed     Text format     Abstract available


  143. ANDRADE SD, Sabido M, Monteiro WM, Benzaken AS, et al
    Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    J Antimicrob Chemother. 2017;72:1774-1783.
    PubMed     Text format     Abstract available


  144. HOBBS MR, Grant CC, Ritchie SR, Chelimo C, et al
    Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 years.
    J Antimicrob Chemother. 2017;72:1832-1840.
    PubMed     Text format     Abstract available


  145. BRETAGNE S, Renaudat C, Desnos-Ollivier M, Sitbon K, et al
    Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
    J Antimicrob Chemother. 2017;72:1784-1793.
    PubMed     Text format     Abstract available


  146. ASSOUMOU L, Charpentier C, Recordon-Pinson P, Grude M, et al
    Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
    J Antimicrob Chemother. 2017;72:1769-1773.
    PubMed     Text format     Abstract available


  147. ZHOU YF, Tao MT, Feng Y, Yang RS, et al
    Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
    J Antimicrob Chemother. 2017;72:1723-1730.
    PubMed     Text format     Abstract available


  148. NISHIKAWA H, Fukuda Y, Mitsuyama J, Tashiro M, et al
    In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    J Antimicrob Chemother. 2017;72:1709-1713.
    PubMed     Text format     Abstract available


  149. TANG Y, Dai L, Sahin O, Wu Z, et al
    Emergence of a plasmid-borne multidrug resistance gene cfr(C) in foodborne pathogen Campylobacter.
    J Antimicrob Chemother. 2017;72:1581-1588.
    PubMed     Text format     Abstract available


  150. KAUSHIK A, Ammerman NC, Tasneen R, Story-Roller E, et al
    In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. HURST SF, Berkow EL, Stevenson KL, Litvintseva AP, et al
    Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  152. ALAUZET C, Berger S, Jean-Pierre H, Dubreuil L, et al
    nimH, a novel nitroimidazole resistance gene contributing to metronidazole resistance in Bacteroides fragilis.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format    


  153. SHU JC, Kuo AJ, Su LH, Liu TP, et al
    Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. AMBROSIONI J, Mosquera MM, Miro JM
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection-authors' response.
    J Antimicrob Chemother. 2017;72:1547-1548.
    PubMed     Text format    


  155. FABRIZIO C, Lepore L, Lagioia A, Punzi G, et al
    Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:1546-1547.
    PubMed     Text format    


  156. PFALLER MA, Bassetti M, Duncan LR, Castanheira M, et al
    Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    J Antimicrob Chemother. 2017;72:1386-1395.
    PubMed     Text format     Abstract available


  157. GOODALL RL, Dunn DT, Nkurunziza P, Mugarura L, et al
    Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
    J Antimicrob Chemother. 2017;72:1450-1455.
    PubMed     Text format     Abstract available


  158. TAM VH, Chang KT, Zhou J, Ledesma KR, et al
    Determining beta-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
    J Antimicrob Chemother. 2017;72:1421-1428.
    PubMed     Text format     Abstract available


  159. GUENTHER S, Falgenhauer L, Semmler T, Imirzalioglu C, et al
    Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms.
    J Antimicrob Chemother. 2017;72:1289-1292.
    PubMed     Text format     Abstract available


  160. DUPRILOT M, Decre D, Genel N, Drieux L, et al
    Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniae.
    J Antimicrob Chemother. 2017;72:1320-1326.
    PubMed     Text format     Abstract available


  161. ROUKENS M, Verhoef L, Stobberingh E, Natsch S, et al
    Surveillance of antimicrobial use in Dutch long-term care facilities.
    J Antimicrob Chemother. 2017;72:1516-1520.
    PubMed     Text format     Abstract available


  162. BALLESTERO-TELLEZ M, Docobo-Perez F, Portillo-Calderon I, Rodriguez-Martinez JM, et al
    Molecular insights into fosfomycin resistance in Escherichia coli.
    J Antimicrob Chemother. 2017;72:1303-1309.
    PubMed     Text format     Abstract available


  163. LANGE F, Pfennigwerth N, Gerigk S, Gohlke F, et al
    Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.
    J Antimicrob Chemother. 2017;72:1334-1339.
    PubMed     Text format     Abstract available


  164. VAN EIJK E, Wittekoek B, Kuijper EJ, Smits WK, et al
    DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2017;72:1275-1284.
    PubMed     Text format     Abstract available


    April 2017
  165. EHRMANN E, Jolivet-Gougeon A, Bonnaure-Mallet M, Fosse T, et al
    Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    J Antimicrob Chemother. 2017 Apr 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. ZIMENKOV DV, Nosova EY, Kulagina EV, Antonova OV, et al
    Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    J Antimicrob Chemother. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. OVEJERO CM, Delgado-Blas JF, Calero-Caceres W, Muniesa M, et al
    Spread of mcr-1-carrying Enterobacteriaceae in sewage water from Spain.
    J Antimicrob Chemother. 2017;72:1050-1053.
    PubMed     Text format     Abstract available


  168. PFENNIGWERTH N, Lange F, Belmar Campos C, Hentschke M, et al
    Genetic and biochemical characterization of HMB-1, a novel subclass B1 metallo-beta-lactamase found in a Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2017;72:1068-1073.
    PubMed     Text format     Abstract available


  169. CROSS EL, Tolfree R, Kipping R
    Systematic review of public-targeted communication interventions to improve antibiotic use.
    J Antimicrob Chemother. 2017;72:975-987.
    PubMed     Text format     Abstract available


  170. WATTAL C, Chakrabarti A, Oberoi JK, Donnelly JP, et al
    Issues in antifungal stewardship: an opportunity that should not be lost.
    J Antimicrob Chemother. 2017;72:969-974.
    PubMed     Text format     Abstract available


  171. JOHNSON AP, Muller-Pebody B, Budd E, Ashiru-Oredope D, et al
    Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.
    J Antimicrob Chemother. 2017;72:953-956.
    PubMed     Text format     Abstract available


  172. CHAPMAN B, Slavin M, Marriott D, Halliday C, et al
    Changing epidemiology of candidaemia in Australia.
    J Antimicrob Chemother. 2017;72:1103-1108.
    PubMed     Text format     Abstract available


  173. MADELAIN V, Le MP, Champenois K, Charpentier C, et al
    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    J Antimicrob Chemother. 2017;72:1137-1146.
    PubMed     Text format     Abstract available


  174. SOUSA DOMINGUEZ A, Perez-Rodriguez MT, Nodar A, Martinez-Lamas L, et al
    Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
    J Antimicrob Chemother. 2017;72:1262-1263.
    PubMed     Text format    


    March 2017
  175. SAN-JUAN R, Fernandez-Ruiz M, Gasch O, Camoez M, et al
    High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  176. FALAGAS ME, Skalidis T, Vardakas KZ, Legakis NJ, et al
    Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  177. ROER L, Hansen F, Thomsen MC, Knudsen JD, et al
    WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. HAMIDIAN M, Nigro SJ, Hartstein RM, Hall RM, et al
    RCH51, a multiply antibiotic-resistant Acinetobacter baumannii ST103IP isolate, carries resistance genes in three plasmids, including a novel potentially conjugative plasmid carrying oxa235 in transposon Tn6252.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  179. HAWKINS PA, Law CS, Metcalf BJ, Chochua S, et al
    Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  180. JAGANATH D, Schaaf HS, Donald PR
    Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
    J Antimicrob Chemother. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  181. GRONTHAL T, Eklund M, Thomson K, Piiparinen H, et al
    Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
    J Antimicrob Chemother. 2017 Mar 8. doi: 10.1093.
    PubMed     Text format    


  182. DE LASTOURS V, Maugy E, Mathy V, Chau F, et al
    Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
    J Antimicrob Chemother. 2017 Mar 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  183. LASS-FLORL C, Cuenca-Estrella M
    Changes in the epidemiological landscape of invasive mould infections and disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  184. STEFIC K, Salmona M, Capitao M, Splittgerber M, et al
    Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.
    J Antimicrob Chemother. 2017;72:850-854.
    PubMed     Text format     Abstract available


  185. SULLY EK, Geller BL, Li L, Moody CM, et al
    Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
    J Antimicrob Chemother. 2017;72:782-790.
    PubMed     Text format     Abstract available


  186. KLETENKOV K, Hoffmann D, Boni J, Yerly S, et al
    Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
    J Antimicrob Chemother. 2017;72:866-875.
    PubMed     Text format     Abstract available


  187. DUGGETT NA, Sayers E, AbuOun M, Ellis RJ, et al
    Occurrence and characterization of mcr-1-harbouring Escherichia coli isolated from pigs in Great Britain from 2013 to 2015.
    J Antimicrob Chemother. 2017;72:691-695.
    PubMed     Text format     Abstract available


  188. BRIAND C, Dollfus C, Faye A, Kantor E, et al
    Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
    J Antimicrob Chemother. 2017;72:837-843.
    PubMed     Text format     Abstract available


    February 2017
  189. LENHARD JR, Thamlikitkul V, Silveira FP, Garonzik SM, et al
    Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  190. MOUGARI F, Loiseau J, Veziris N, Bernard C, et al
    Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  191. CAVANAUGH JS, Jou R, Wu MH, Dalton T, et al
    Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    J Antimicrob Chemother. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  192. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study.
    J Antimicrob Chemother. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  193. BOIKOV DA, Locke JB, James KD, Bartizal K, et al
    In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


  194. LI R, Xie M, Zhang J, Yang Z, et al
    Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant.
    J Antimicrob Chemother. 2017;72:393-401.
    PubMed     Text format     Abstract available


  195. BOERMA RS, Sigaloff KC, Akanmu AS, Inzaule S, et al
    Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2017;72:365-371.
    PubMed     Text format     Abstract available


  196. ZAHEDI BIALVAEI A, Rahbar M, Yousefi M, Asgharzadeh M, et al
    Linezolid: a promising option in the treatment of Gram-positives.
    J Antimicrob Chemother. 2017;72:354-364.
    PubMed     Text format     Abstract available


  197. ROMINSKI A, Roditscheff A, Selchow P, Bottger EC, et al
    Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
    J Antimicrob Chemother. 2017;72:376-384.
    PubMed     Text format     Abstract available


  198. BEYROUTHY R, Robin F, Hamze M, Bonnet R, et al
    IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2.
    J Antimicrob Chemother. 2017;72:402-406.
    PubMed     Text format     Abstract available


  199. PADGET M, Tamarelle J, Herindrainy P, Ndir A, et al
    A community survey of antibiotic consumption among children in Madagascar and Senegal: the importance of healthcare access and care quality.
    J Antimicrob Chemother. 2017;72:564-573.
    PubMed     Text format     Abstract available


  200. GONZALEZ-SERNA A, Glas AC, Brumme CJ, Poon AF, et al
    Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.
    J Antimicrob Chemother. 2017;72:496-503.
    PubMed     Text format     Abstract available


  201. TAN C, Vermeulen M, Wang X, Zvonar R, et al
    Variability in antibiotic use across Ontario acute care hospitals.
    J Antimicrob Chemother. 2017;72:554-563.
    PubMed     Text format     Abstract available


  202. BAILEY C, Tully MP, Pampaka M, Cooke J, et al
    Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17).
    J Antimicrob Chemother. 2017;72:604-613.
    PubMed     Text format     Abstract available


  203. NY S, Lofmark S, Borjesson S, Englund S, et al
    Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study.
    J Antimicrob Chemother. 2017;72:582-588.
    PubMed     Text format     Abstract available


  204. BISSIO E, Barbas MG, Bouzas MB, Cudola A, et al
    Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.
    J Antimicrob Chemother. 2017;72:504-510.
    PubMed     Text format     Abstract available


  205. SADAHIRA T, Wada K, Araki M, Ishii A, et al
    Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    J Antimicrob Chemother. 2017;72:529-534.
    PubMed     Text format     Abstract available


  206. TREPANIER P, Mallard K, Meunier D, Pike R, et al
    Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    J Antimicrob Chemother. 2017;72:596-603.
    PubMed     Text format     Abstract available


  207. CABELLO FC, Godfrey HP
    Comment on: Transferable resistance to colistin: a new but old threat.
    J Antimicrob Chemother. 2017;72:636-637.
    PubMed     Text format    


    January 2017
  208. LEDDA A, Price JR, Cole K, Llewelyn MJ, et al
    Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Jan 20. pii: dkw570. doi: 10.1093.
    PubMed     Text format     Abstract available


  209. STONE GG, Bradford PA, Yates K, Newell P, et al
    In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
    J Antimicrob Chemother. 2017 Jan 14. pii: dkw561. doi: 10.1093.
    PubMed     Text format     Abstract available


  210. XISTO MI, Caramalho RD, Rocha DA, Ferreira-Pereira A, et al
    Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw558. doi: 10.1093.
    PubMed     Text format     Abstract available


  211. OTSUKA T, Brauer AL, Kirkham C, Sully EK, et al
    Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.
    J Antimicrob Chemother. 2017;72:137-144.
    PubMed     Text format     Abstract available


  212. CUNNINGHAM E, Chan YT, Aghaizu A, Bibby DF, et al
    Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.
    J Antimicrob Chemother. 2017;72:227-234.
    PubMed     Text format     Abstract available


  213. DEGHMANE AE, Hong E, Taha MK
    Emergence of meningococci with reduced susceptibility to third-generation cephalosporins.
    J Antimicrob Chemother. 2017;72:95-98.
    PubMed     Text format     Abstract available


  214. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    J Antimicrob Chemother. 2017;72:210-219.
    PubMed     Text format     Abstract available


  215. SHARMA A, Sharma R, Bhattacharyya T, Bhando T, et al
    Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF.
    J Antimicrob Chemother. 2017;72:68-74.
    PubMed     Text format     Abstract available


  216. AMBROSIONI J, Nicolas D, Manzardo C, Aguero F, et al
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:205-209.
    PubMed     Text format     Abstract available


    December 2016
  217. ZHU XQ, Wang XM, Li H, Shang YH, et al
    Novel lnu(G) gene conferring resistance to lincomycin by nucleotidylation, located on Tn6260 from Enterococcus faecalis E531.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw549. doi: 10.1093.
    PubMed     Text format     Abstract available


  218. BUTIN M, Martins-Simoes P, Pichon B, Leyssene D, et al
    Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw516. doi: 10.1093.
    PubMed     Text format     Abstract available


  219. BRITT NS, Patel N, Shireman TI, El Atrouni WI, et al
    Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw453. doi: 10.1093.
    PubMed     Text format     Abstract available


  220. CAVACO LM, Bernal JF, Zankari E, Leon M, et al
    Detection of linezolid resistance due to the optrA gene in Enterococcus faecalis from poultry meat from the American continent (Colombia).
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw490. doi: 10.1093.
    PubMed     Text format     Abstract available


  221. TANIGUCHI R, Kimura K, Miyazaki A, Banno H, et al
    High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw500. doi: 10.1093.
    PubMed     Text format    


    November 2016
  222. SWEENEY D, Stoneburner A, Shinabarger DL, Arhin FF, et al
    Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


    September 2016
  223. MULDER M, Kiefte-de Jong JC, Goessens WH, de Visser H, et al
    Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  224. KUBICEK-SUTHERLAND JZ, Lofton H, Vestergaard M, Hjort K, et al
    Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  225. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  226. MORICI E, Simoni S, Brenciani A, Giovanetti E, et al
    A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)].
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  227. MENDES RE, Castanheira M, Farrell DJ, Flamm RK, et al
    Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    August 2016
  228. CHONG GM, van der Beek MT, von dem Borne PA, Boelens J, et al
    PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay(R) in 201 patients with haematological disease suspected for invasive aspergillosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  229. LAHIRI SD, Alm RA
    Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  230. VERWEIJ PE, Lestrade PP, Melchers WJ, Meis JF, et al
    Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?
    J Antimicrob Chemother. 2016;71:2079-82.
    PubMed     Text format     Abstract available


  231. ALANIO A, Denis B, Hamane S, Raffoux E, et al
    New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
    J Antimicrob Chemother. 2016;71:2075-8.
    PubMed     Text format     Abstract available


    July 2016
  232. TSAO S, Weber S, Cameron C, Nehme D, et al
    Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    June 2016
  233. SINEL C, Cosquer T, Auzou M, Goux D, et al
    Sequential steps of daptomycin resistance in Enterococcus faecium and reversion to hypersusceptibility through IS-mediated inactivation of the liaFSR operon.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  234. PFALLER MA, Messer SA, Rhomberg PR, Jones RN, et al
    Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  235. EILERTSON B, Maruri F, Blackman A, Guo Y, et al
    A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    May 2016
  236. SEROY JT, Grim SA, Reid GE, Wellington T, et al
    Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  237. PANTEL A, Petrella S, Veziris N, Matrat S, et al
    Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  238. LIU P, Xue H, Wu Z, Ma J, et al
    Effect of bla regulators on the susceptible phenotype and phenotypic conversion for oxacillin-susceptible mecA-positive staphylococcal isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    April 2016
  239. DEPLANO A, Vandendriessche S, Nonhoff C, Dodemont M, et al
    National surveillance of Staphylococcus epidermidis recovered from bloodstream infections in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    March 2016
  240. LIN YT, Tsai JC, Yamamoto T, Chen HJ, et al
    Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: